CA9 and renal cell carcinoma: The DNA vaccine was composed of plasmid DNA encoding G250 protein (also known as carbonic anhydrase-9 that is abundantly expressed on RCC tumor cells but not on the normal non-cancerous cells) fused with the major immune-dominant region of the HBcAg gene.